We are live on ! Find out more
TRAW icon

Traws Pharma

24 hedge funds and large institutions have $1.04M invested in Traws Pharma in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.66% less ownership

Funds ownership: 7.48% → 6.81% (-0.66%)

14% less funds holding

Funds holding: 28 → 24 (-4)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

77% less capital inflows, than outflows

Capital inflows: $30.1K | Capital outflows: $133K

86% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 7

Holders
24
Holders Change
-4
Holders Change %
-14.29%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
7
Closed
6
Calls
$2​K
Puts
–
Net Calls
+$2​K
Net Calls Change
-⁠$147​K

TRAW Hedge Fund Activity: Q1 2023 in Review

24 of the 6,286 institutional investors tracked by Wall St. Rank reported a position in Traws Pharma (TRAW) for Q1 2023, worth a combined $1.04M — up 3.2% from $1.01M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of TRAW and 3 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 1 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $24.6K. The largest seller was Beacon Pointe Advisors, cutting an estimated $22.7K.

  • 24 institutional investors held Traws Pharma (TRAW) as of Q1 2023, down from 28 in Q4 2022.
  • Funds reported $1.04M of Traws Pharma stock for Q1 2023, up 3.2% quarter-over-quarter.
  • 3 funds opened new Traws Pharma positions in Q1 2023 and 6 closed out, a net change of -3 holders.
  • The largest Traws Pharma buyer in Q1 2023 was Susquehanna International Group, an estimated $24.6K added.
  • The largest Traws Pharma seller in Q1 2023 was Beacon Pointe Advisors, an estimated $22.7K sold.

Based on aggregated 13F filings for Q1 2023.